uvstocks.io

Today’s CSR movers

ETR 4.0 ▲ 1.5

SO 3.0 ▲ 1.0

NTAP 3.6 ▲ 0.5

PWR 4.6 ▲ 0.5

SNPS 4.6 ▲ 0.5

APA 3.1 ▲ 0.1

ITW 2.7 ▲ 0.1

CF 2.9 ▼ 0.1

VMC 3.7 ▼ 0.1

COO 3.6 ▼ 0.1

Health Care · NYSE NYSE · A

Agilent Technologies

$146.93 +$3.91 +2.66% CLOSE 09.11.26 AFTER HOURS $146.93

Convergence score

4.0 / 5.0 STRONG BULLISH

+0.0 vs last report

Overall valuation

Overvalued

Aggregated across multiple horizons

Consensus target (12mo)

$173.41 +18.0%

Range $135.00 — $190.00

Sector

Health Care

NYSE · Tracked daily

Today's snapshot

Where the signals stand.

REPORT 09.11.26

UV Convergence Score

REPORT 09.11.26

4.0

/ 5.0

STRONG BULLISH

Consensus signal A

4.0

Consensus signal B

4.0

Consensus signal D

4.0

Analyst average

4.3

Multi-signal aggregate How CSR works →

Day Range

$144.48 – $146.97

52W Range

$108.35 – $163.75

Volume

1.8M

Avg Vol

2.2M

Mkt Cap

$41.42B

P/E

28.98

EPS (TTM)

$5.07

Div Yield

0.71%

Beta

1.24

Today's convergence

Convergence score sits at 4.0 with overall valuation reading as overvalued. Drivers across the horizons inform the aggregate. Open the deep dives for valuation, analyst, or financial detail.

Valuation

Overvalued

CSR direction

STRONG BULLISH

Last close

$146.93

Sector

Health Care

Valuation

Three horizons

UPDATED 09.11.26

Short term

0–3 MO

No target —

Medium term

3–12 MO

$170+15.9% Buy

Long term

12–36 MO

$91.00-38.1% Overvalued

Open valuation →

Analysts

Coverage & consensus

3 PANELS

Mean target (12mo)

$173.41 +18.0%

RANGE $135.00 — $190.00

Analyst consensus

Consensus rating Buy

Blended score 4.1 / 5

Analysts tracked 64

Open analysts →

Financials

Key metrics

LATEST

P/E

28.98

EPS (TTM)

$5.07

Mkt Cap

$41.42B

Div Yield

0.71%

Beta

1.24

52W Range

$108.35 – $163.75

Open financials →

Reports

Valuation breakdown

Three horizons, one consensus.

UPDATED 09.11.26

Short term

0–3 MO

—

Consensus target

No target available

Medium term

3–12 MO

Buy

Consensus target

$170 +15.9%

RANGE $135 – $190

$135NOW $146.93$190

12-month analyst consensus target across covering brokerages.

Long term

12–36 MO

Overvalued

Consensus target

$91.00 -38.1%

UVStocks in-house sector-relative valuation model.

Signal breakdown

What’s driving the score.

EACH SIGNAL RATED 1.0 — 5.0

Top-level breakdown

Valuation:	PE Ratio: 28.98	PEG Ratio: -	DE Ratio: -
Free Cash Flow: $1.06B	PB Ratio: -	PS Ratio: -	Dividend: $0.25

Analyst coverage

Blended analyst consensus & targets.

3 PANELS · UPDATED 09.11.26

Analyst consensus RATING · SCORE · PANELS · ANALYSTS

Rating Blended score Panels Analysts

Buy 4.1 3 64

Price targets LOW · MEAN · MEDIAN · HIGH · UPSIDE

Coverage Low Mean Median High Upside

All panels $135.00 $173.41 $175.00 $190.00 +18.0%

Rating distribution STRONG BUY · BUY · HOLD · SELL · STRONG SELL

Coverage SB B H S SS

All panels 6 26 11 0 0

Rating trend CURRENT VS 1M / 2M / 3M

Period Rating Avg Analysts

Current — — —

1 Mo Ago — — —

2 Mo Ago — — —

3 Mo Ago — — —

Most recent analyst action LATEST DESK ACTION

Date

9/9/2026

Firm

UBS Group

Action

Initiated Coverage

Rating

Neutral

Target

$165.00

Full financial snapshot.

UPDATED 09.11.26

Quote snapshot 15 FIELDS

Prev Close

$143.12

Open

$144.48

Day Low

$144.48

Day High

$146.97

Bid

$141.90

Ask

$148.02

52W Low

$108.35

52W High

$163.75

50D Avg

$142.99

200D Avg

$131.60

Volume

1.8M

Avg Vol

2.2M

10D Avg Vol

2.4M

52W Change

16.13%

S&P 52W Change

15.30%

Valuation ratios 10 FIELDS

P/E (TTM)

28.98

P/E (Fwd)

21.74

PEG (Fwd)

1.20

P/S

5.62

P/B

5.63

Book Value

$26.11

EV/Revenue

5.94

EV/EBITDA

21.06

Mkt Cap

41.42B

Enterprise Val

43.81B

Profitability & returns 6 FIELDS

Profit Margin

19.53%

Gross Margin

53.65%

Operating Margin

25.56%

EBITDA Margin

28.22%

Return on Assets

8.63%

Return on Equity

20.97%

Growth 3 FIELDS

Revenue Growth (YoY)

8.10%

Earnings Growth (YoY)

8.50%

Earnings Growth (Q)

7.70%

Balance sheet & cash flow 11 FIELDS

Total Revenue

7.37B

EBITDA

2.08B

Total Cash

1.76B

Total Debt

4.15B

Cash / Share

$6.24

Revenue / Share

$26.10

Free Cash Flow

1.06B

Operating CF

1.61B

Debt / Equity

56.34

Current Ratio

2.05

Quick Ratio

1.41

Dividend 5 FIELDS

Fwd Dividend

1.02 (0.71%)

Dividend Yield

0.71%

Payout Ratio

19.98%

5Y Avg Yield

0.69%

Ex-Div Date

2026-06-30

Share statistics 7 FIELDS

Shares Out

281.93M

Float

280.96M

Shares Short

5.68M

% Short of Float

2.29%

Short Ratio

2.76

% Held Insiders

0.19%

% Held Institutions

95.47%

Calendar & events 5 FIELDS

Next Earnings

2026-11-25

Fiscal Year End

2025-10-31

Most Recent Qtr

2026-07-31

Last Split

1398:1000

Split Date

2014-11-03

Company 2 FIELDS

Industry

Diagnostics & Research

Employees

18,200